Advisory Services Network, LLC Dbv Technologies S.A. Transaction History

Advisory Services Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.7 - $1.33 $909 - $1,729	1,300 New	1,300 $1,000
Q1 2023 May 17, 2023	SELL	$1.28 - $1.73 $3,840 - $5,190	-3,000 Reduced 75.0%	1,000 $1,000
Q4 2022 Feb 13, 2023	BUY	$1.16 - $1.8 $4,640 - $7,200	4,000 New	4,000 $6,000
Q2 2022 Aug 02, 2022	BUY	$1.15 - $3.25 $11,500 - $32,500	10,000 New	10,000 $26,000
Q4 2020 Feb 09, 2021	SELL	$1.38 - $3.01 $206 - $451	-150 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.58 - $4.77 $237 - $715	150 New	150 $0

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $88.3M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.